Abstract:Porcine rotaviruses (PoRVs) cause severe economic losses in the swine industry. P[7] and P[23] are the predominant genotypes circulating on farms, but no vaccine is yet available. Here, we developed a bivalent subunit PoRV vaccine using truncated versions (VP4*) of the VP4 proteins from P[7] and P[23]. The vaccination of mice with the bivalent subunit vaccine elicited more robust neutralizing antibodies (NAbs) and cellular immune responses than its components, even at high doses. The bivalent subunit vaccine and inactivated bivalent vaccine prepared from strains PoRVs G9P[7] and G9P[23] were used to examine their protective efficacy in sows and suckling piglets after passive immunization. The immunized sows showed significantly elevated NAbs in the serum and colostrum, and the suckling piglets acquired high levels of sIgA antibodies from the colostrum. Challenging subunit-vaccinated or inactivated-vaccinated piglets with homologous virulent strains did not induce diarrhea, except in one or two piglets, which had mild diarrhea. Immunization with the bivalent subunit vaccine and inactivated vaccine also alleviated the microscopic lesions in the intestinal tissues caused by the challenge with the corresponding homologous virulent strain. However, all the piglets in the challenged group displayed mild to watery diarrhea and high levels of viral shedding, whereas the feces and intestines of the piglets in the bivalent subunit vaccine and inactivated vaccine groups had lower viral loads. In summary, our data show for the first time that a bivalent subunit vaccine combining VP4*P[7] and VP4*P[23] effectively protects piglets against the diarrhea caused by homologous virulent strains.IMPORTANCEPoRVs are the main causes of diarrhea in piglets worldwide. The multisegmented genome of PoRVs allows the reassortment of VP4 and VP7 genes from different RV species and strains. The P[7] and P[23] are the predominant genotypes circulating in pig farms, but no vaccine is available at present in China. Subunit vaccines, as nonreplicating vaccines, are an option to cope with variable genotypes. Here, we have developed a bivalent subunit candidate vaccine based on a truncated VP4 protein, which induced robust humoral and cellular immune responses and protected piglets against challenge with homologous PoRV. It also appears to be safe. These data show that the truncated VP4-protein-based subunit vaccine is a promising candidate for the prevention of PoRV diarrhea.

Identification and characterization of porcine rotavirus VP7 protein mimotope by phage screening technique

Protein Expression and Receptor Binding Specificity of Porcine P[19] Rotavirus VP8*

Longitudinal Surveillance of Porcine Rotavirus B Strains from the United States and Canada and In Silico Identification of Antigenically Important Sites

Cloning and Sequence Analysis of Gene Encoding Outer Capsid Protein VP7 of Porcine Rotavirus(rv) JL94 Strain Isolated in China

Virus-like Particles vaccine based on co-expression of G5 Porcine rotavirus VP2-VP6-VP7 induces a powerful immune protective response in mice

The epitope of the VP1 protein of porcine parvovirus

Expression VP4 complete protein and polyclonal antibodies prepara-tion or detection of porcine rotavirus DN30209 strain

Molecular Characterization and Pathogenicity Analysis of Porcine Rotavirus A

Recent Molecular Characterization of Porcine Rotaviruses Detected in China and Their Phylogenetic Relationships with Human Rotaviruses

Leveraging a Validated in silico Approach to Elucidate Genotype-Specific VP7 Epitopes and Antigenic Relationships of Porcine Rotavirus A

Phages Bearing Affinity Peptides to Bovine Rotavirus Differentiate the Virus from Other Viruses

Auxotrophic Lactobacillus Expressing Porcine Rotavirus VP4 Constructed Using CRISPR-Cas9D10A System Induces Effective Immunity in Mice

Identification of a Dominant Linear Epitope on the VP2 Capsid Protein of Porcine Parvovirus and Characterization of Two Monoclonal Antibodies with Neutralizing Abilities.

GENETIC ANALYSIS OF PORCINE ROTAVIRUS INFECTION IN PIGLETS

Recombinant bivalent subunit vaccine combining truncated VP4 from P[7] and P[23] induces protective immunity against prevalent porcine rotaviruses

Development of porcine rotavirus vp6 protein based ELISA for differentiation of this virus and other viruses

The synergy of recombinant NSP4 and VP4 from porcine rotavirus elicited a strong mucosal response

Preparation and Identification of Monoclonal Antibodies Against Porcine Rotavirus VP6

Isolation and Pathogenicity Analysis of a G5P[23] Porcine Rotavirus Strain

Development and evaluation of polyclonal antibodies based antigen capture ELISA for detection of porcine rotavirus

Evaluation of the immunogenicity of auxotrophic Lactobacillus with CRISPR-Cas9D10A system-mediated chromosomal editing to express porcine rotavirus capsid protein VP4